Patents Assigned to Teagasc
-
Patent number: 11833178Abstract: A strain of Bifidobacterium longum APC 1472 is described. The strain has weight lowering effects in-vivo, achieved through inducing satiety via decreased internalisation of the Ghrelin receptor, and therefore, decreased constitutive activity. Moreover, the strain also showed a trend towards decreased ghrelin receptor hypothalamic expression in HFD-fed mice when compared with vehicle control group. The strain also improves glucose tolerance and decreased insulin plasma levels in mice, indicating the strain in the prevention and/or treatment of Type II diabetes, especially in obese individuals.Type: GrantFiled: August 27, 2018Date of Patent: December 5, 2023Assignees: UNIVERSITY COLLEGE CORK—NATIONAL UNIVERSITY OF IRELAND, CORK, AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY (TEAGASC)Inventors: John Cryan, Ted Dinan, Catherine Stanton, Harriet Schellekens, Cristina Torres, Bernard Roy
-
Publication number: 20230172221Abstract: A method for preparing a kefir product involves providing bacterial strains selected from Acetobacter, Leuconostoc, Lactococcus, or Lactobacillus; providing yeast strains selected from Pichia, Saccharomyces, Kazachstania, or Kluyveromyces; adding the bacterial and yeast strains to milk to form a mixture; and allowing the mixture to ferment to yield the kefir product.Type: ApplicationFiled: March 3, 2020Publication date: June 8, 2023Applicants: The Governors of the University of Alberta, Teagasc, The Agriculture and Food Development AuthorityInventors: Benjamin WILLING, Benjamin BOURRIE, Paul COTTER
-
Patent number: 11324232Abstract: A method of sequential isoelectric solubilisation of animal by-product comprising the steps of isoelectric solubilisation of the animal by-product in one of an acid or alkali solution to provide a first solubilised protein fraction, separating the first solubilised protein fraction from unsolubilised animal by-product, isoelectric solubilisation of the unsolubilised animal by-product to provide a second solubilised protein fraction, and separation of the second solubilised protein fraction from unsolubilised animal by-product. The protein from the first and/or second solubilised protein fractions is recovered by drying or precipitation. In one embodiment, the acid and alkali soluble protein fractions are proportionally combined to neutralise the composite fraction and precipitate protein.Type: GrantFiled: July 15, 2016Date of Patent: May 10, 2022Assignee: AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY (TEAGASC)Inventors: Brijesh K. Tiwari, Carlos Alvarez Garcia, Declan Troy
-
Publication number: 20210163878Abstract: The current invention provides use of a CLA-producing bacterium for the in vivo conversion in the gut of polyunsaturated fatty acids to CLA. The CLA-producing bacterium is selected from one or more of the group consisting of propionibacteria, lactobacilli, lactococci and streptococci, and bifidobacteria.Type: ApplicationFiled: December 14, 2020Publication date: June 3, 2021Applicants: PrecisionBiotics Group Limited, University College Cork, National University of Ireland, Teagasc - The Agriculture and Food Development AuthorityInventors: Liam O'Mahony, Fergus Shanahan, Eamonn Quigley, Paul Ross, Catherine Stanton
-
Publication number: 20190264168Abstract: The current invention provides use of a CLA-producing bacterium for the in vivo conversion in the gut of polyunsaturated fatty acids to CLA. The CLA-producing bacterium is selected from one or more of the group consisting of propionibacteria, lactobacilli, lactococci and streptococci, and bifidobacteria.Type: ApplicationFiled: December 3, 2018Publication date: August 29, 2019Applicants: University College Cork, National University of Ireland, Teagasc- The Agriculture and Food Development Authority, Alimentary Health Ltd.Inventors: Liam O'Mahony, Fergus Shanahan, Eamonn Quigley, Paul Ross, Catherine Stanton
-
Patent number: 9808493Abstract: An isolated Lactobacillus mucosae (DPC6426) strain deposited with the National Collection of Industrial and Marine Bacteria Limited (NCIMB) on 27 Jul. 2012 under NCIMB Deposit Accession No. 42015.Type: GrantFiled: September 2, 2013Date of Patent: November 7, 2017Assignees: University College Cork—National University of Ireland, Cork, Agriculture and Food Development Authority (TEAGASC)Inventors: Catherine Stanton, Paul Ross, Gerald F. Fitzgerald, Noel Caplice, Fergus Shanahan
-
Publication number: 20170253638Abstract: An antimicrobial peptide having potent antibacterial activity against Listeria monocytogenes and Staphylococcus aureus is described. Also described is an isolated Lactobacillus salivarius DPC6502 strain as deposited with the National Collection of Industrial and Marine Bacteria under the Accession No. NCIMB 41840, and variants thereof, wherein the isolated bacteria and variants thereof express an antimicrobial peptide of the invention.Type: ApplicationFiled: April 3, 2017Publication date: September 7, 2017Applicants: UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK, AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY (TEAGASC)Inventors: Paul ROSS, Eileen O'SHEA, Colin HILL
-
Publication number: 20170152547Abstract: Provided herein are methods and kits directed to a method of assaying a sample to determine the presence of a source of pink discoloration defect of a dairy product, such as cheese. In some embodiments, the method comprises the steps of assaying the sample to detect the presence of a Thermus species of bacteria, such as Thermus thermophilus bacteria, wherein detection of Thermus thermophilus bacteria in the sample indicates that the sample contains a source of pink discoloration of a dairy product.Type: ApplicationFiled: June 19, 2015Publication date: June 1, 2017Applicant: AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY (TEAGASC)Inventors: Paul Cotter, Diarmuid Sheehan, Lisa Quigley
-
Patent number: 9597362Abstract: The disclosure relates to the live cultures of probiotic bacteria to treat infectious diseases in humans and animals. Food-grade or non-pathogenic cultures are used to treat localised infections.Type: GrantFiled: October 15, 2004Date of Patent: March 21, 2017Assignees: TEAGASC, THE AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY, UNIVERSITY COLLEGE, CORK-NATIONAL UNIVERSITY OF IRELANDInventors: Paul Ross, Colin Hill, William Meaney
-
Patent number: 8852917Abstract: The present invention relates to a new bacteriocin, to microbial strains which can produce it and to uses of the bacteriocin and the strains. The bacteriocin is effective against Clostridium difficile and Listeria monocytogenes amongst other organisms.Type: GrantFiled: November 28, 2008Date of Patent: October 7, 2014Assignees: University College Cork, TEAGASC, The Agriculture and Food Development AuthorityInventors: Colin Hill, Mary Rea, Paul Ross
-
Publication number: 20140286904Abstract: An antimicrobial peptide having potent antibacterial activity against Listeria monocytogenes and Staphylococcus aureus is described. Also described is an isolated Lactobacillus salivarius DPC6502 strain as deposited with the National Collection of Industrial and Marine Bacteria under the Accession No. NCIMB 41840, and variants thereof, wherein the isolated bacteria and variants thereof express an antimicrobial peptide of the invention.Type: ApplicationFiled: July 27, 2012Publication date: September 25, 2014Applicants: AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY (TEAGASC), UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORKInventors: Paul Ross, Eileen O'Shea, Colin Hill
-
Publication number: 20130209429Abstract: The current invention provides use of a CLA-producing bacterium for the in vivo conversion in the gut of polyunsaturated fatty acids to CLA. The CLA-producing bacterium is selected from one or more of the group consisting of propionibacteria, lactobacilli, lactococci and streptococci, and bifidobacteria.Type: ApplicationFiled: March 27, 2013Publication date: August 15, 2013Applicants: University College Cork, National University of Ireland, Cork, Alimentary Health Ltd., TEAGASC - The Agriculture and Food Development AuthorityInventors: University College Cork, National University of Ireland, Cork, TEAGASC - The Agriculture and Food Development Authority, Alimentary Health Ltd.
-
Publication number: 20130005647Abstract: A Nisin derivative or variant, comprising an amino acid substitution at amino acid position 29 in the amino acid sequence. The Nisin derivative exhibits enhanced antimicrobial activity when compared to wild type Nisin. The Nisin derivative has an application as a natural food additive and as a therapeutic agent.Type: ApplicationFiled: December 22, 2010Publication date: January 3, 2013Applicants: University College Cork, National University of Ireland, Teagasc, The Agriculture and Food Development AuthorityInventors: Colin Hill, Paul Cotter, Paul R. Ross, Desmond Field
-
Publication number: 20120177608Abstract: An isolated bacteriophage MR299-2 or NH-4 deposited under NCIMB Deposit Accession Nos. 41729 and 41730, respectively, is described. The phages have lytic activity against P. aeruginosa strains, including mucoid and CF clinical isolate strains. Variant hages are also described, wherein said variants retain the phenotypic characteristics of said phage and wherein said phage and variants thereof have lytic activity against P. aeruginosa strains.Type: ApplicationFiled: December 20, 2011Publication date: July 12, 2012Applicants: AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY (TEAGASC), UNIVERSITY COLLEGE CORK, NATIONAL UNIVERSITY OF IRELAND, CORKInventors: Paul Ross, Debebe Alemayehu, Colin Hill, James Gerard Martin
-
Publication number: 20100284979Abstract: The current invention provides use of a CLA-producing bacterium for the in vivo conversion in the gut of polyunsaturated fatty acids to CLA. The CLA-producing bacterium is selected from one or more of the group consisting of propionibacteria, lactobacilli, lactococci and streptococci, and bifidobacteria.Type: ApplicationFiled: September 30, 2008Publication date: November 11, 2010Applicants: UNIVERSITY COLLEGE CORK, NATIONAL UNIVERSITY OF IRELAND, CORK, TEAGASC, The Agriculture and Food Development Authority, ALIMENTARY HEALTH LTD.Inventors: Liam O'Mahony, Fergus Shanahan, Eamonn Quigley, Paul Ross, Catherine Stanton
-
Publication number: 20090214498Abstract: The present invention relates generally to the field of health promoting agents, in particular antimicrobial agents and provides antimicrobial peptides and bacterial strains that provide the antimicrobial peptides. In one aspect, the invention provides a biologically pure culture of Lactobacillus acidophilus, strain DPC6026, a sample of which has been deposited at the National Collection of Industrial and Marine Bacteria, Aberdeen, Scotland on 18th Nov. 2005 under the accession number NCIMB 41354, or a derivative or mutant thereof capable of producing from milk or a milk product, peptides having antimicrobial activity.Type: ApplicationFiled: November 20, 2006Publication date: August 27, 2009Applicant: TEAGASC- NATIONAL DIARY PRODUCTS RESEARCH CENTREInventors: Paul Ross, Catherine Stanton, Colin Hill, Ger Fitzgerald
-
Publication number: 20090105341Abstract: The present application is directed to a process for the production of trans-10, cis-12 conjugated linoleic acid in a transgenic microorganism comprising the steps of: (a) introducing into said microorganism at least one nucleic acid molecule encoding a trans-10, cis-12 conjugated linoleic acid isomerase, (b) culturing the transgenic microorganism obtained under (a), (c) inducing the production of trans-10, cis-12 conjugated linoleic acid by adding linoleic acid to the culture, (d) incubating the induced culture for at least 12 hours, and (e) isolating the conjugated linoleic acid from the culture media and/or transgenic microorganism.Type: ApplicationFiled: November 29, 2006Publication date: April 23, 2009Applicant: Teagasc Dairy Products Research CentreInventor: Catherine Stanton
-
Patent number: 7223543Abstract: The present invention relates to a process for the production of conjugated linoleic acid and a process for the production of triglycerides with an increased content of conjugated linoleic acid. Moreover, the invention relates to a nucleic acid sequence; a nucleic acid construct, a vector and transgenic organisms comprising at least one nucleic acid sequence or one nucleic acid construct which encodes a polypeptide with conjugated linoleic isomerase activity. Furthermore, the invention relates to the use of a microorganism of the genus Bifidobacterium as a probiotic.Type: GrantFiled: June 10, 2002Date of Patent: May 29, 2007Assignee: Teagasc Dairy Products Research CentreInventors: Catherine Stanton, R. Paul Ross, Oskar Zelder, Bruno Kaesler
-
Patent number: 6872411Abstract: A process for the manufacture of a probiotic cheese, such as Cheddar cheese, comprises adding a 0.0-5.5% inoculum of a strain of Lactobacillus paracasei, which is non-pathogenic, acid and bile tolerant and adherent to human epithelial cells, as a starter adjunct to cheese milk, said L. paracasei strain being capable of growing during the ripening phase to a level of 107 cfu/g or greater. The L. paracasei strains are found to grow and proliferate to high cell numbers (in excess of 108 cfu/g) in the cheese over eight months of ripening, even when added at a relatively low inoculum. The presence of the L. paracasei strains is found to have negligible effects on cheese composition, flavor and aroma.Type: GrantFiled: May 26, 1999Date of Patent: March 29, 2005Assignees: Enterprise Ireland, Teagasc, The Agriculture and Food Development AuthorityInventors: Reynolds Paul Ross, Gerald Francis Fitzgerald, John Kevin Collins, Gerald Christopher O'Sullivan, Catherine Gerardine Stanton
-
Patent number: 6833150Abstract: The production of a spray-dried bacteriocin lacticin 3147 powder is described. The powder is shown to have effective anti-microbial activity in a range of foodstuffs, namely infant milk formulations, powdered soup, yoghurt and cottage cheese. Increased anti-microbial activity was demonstrated when the lacticin 3147 powder was used in conjunction with increased hydrostatic pressure. The process comprises: inoculating a medium with a lacticin 3147-producing strain of bacteria, fermenting the inoculated medium, adjusting the pH of the fermentation to 6.3-6.7, inactivating the bacterial fermentate and evaporating the fermentate.Type: GrantFiled: March 7, 2001Date of Patent: December 21, 2004Assignees: Teagasc, The Agriculture and Food Development Authority, National University of IrelandInventors: Reynolds Paul Ross, Colin Hill